When flow cytometry and RT-qPCR analyses were conducted for immune cells isolated from the tumor tissues, we found that erastin by itself did not change the number of activated immune cells, including macrophages, dendritic cells, myeloid-derived suppressor cells (MDSCs), and CD4+ and CD8+ T cells. Here, CD8A is linked to neoplasm.